Dr. Heleen Maes
ActiveSummary
Dr. Heleen Maes has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €248k and a net result of €247k. Equity is growing by ~29.9% per year across the filed fiscal years. Its solvency ranks better than 50% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
85
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+1
Solvency88▼-12
Growth78▲+26
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €21k at 30 days acceptable
Liquidity ample (current ratio 3.92 against 7.75 in 2024; short-term debt: 19.9% and cash: 13.8% of total assets), and 36.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
63.4%
Return on assets
63.1%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 15-01-2026, 16 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
16 d early
2024
15 d early
2023
2 d early
2022
7 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close24-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€248k▼ 61.7%
2024 · €646k
2022: €229k
2023: €445k
2024: €646k
2022 → 2025
Total assets
€391k▼ 52.3%
2024 · €819k
2022: €318k
2023: €592k
2024: €819k
2022 → 2025
Net result
€247k▲ 22.8%
2024 · €201k
2022: €229k
2023: €216k
2024: €201k
2022 → 2025
Working capital
€228k▼ 63.4%
2024 · €623k
2022: €226k
2023: €441k
2024: €623k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€229k-€445k▲ 94.0%€646k▲ 45.2%€248k▼ 61.7%
Operating result€302k-€285k▼ 5.6%€264k▼ 7.2%€325k▲ 23.0%
Net result€229k-€216k▼ 5.9%€201k▼ 6.8%€247k▲ 22.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 23% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €391k
Fixed assets
€85k ▼ 17.9%
Current assets
€306k ▼ 57.3%
Equity and liabilities €391k
Equity
€248k ▼ 61.7%
Debt
€143k ▼ 17.4%
Debt's share of the balance-sheet total rises from 21.2% to 36.6%. Equity and debt are lower.
Key figures and ratios
EBITDA
€348k▲
2024 · €270k
Cash flow
€269k▲
2024 · €206k
Current ratio
3.92▼
2024 · 7.75
Debt to equity
0.58▲
2024 · 0.27
ROE
99.6%▲
2024 · 31.1%
ROA
63.1%▲
2024 · 24.5%
Interest coverage
44.29▼
2024 · 244.04
Debt ≤ 1 year
€78k▼
2024 · €92k
Debt > 1 year
€61k▼
2024 · €80k
Income taxes
€79k▲
2024 · €65k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 49 lines
Balance sheet
Code20242025
Assets
Total assets20/58€819k€391k▼
Formation expenses20€387€194▼
Fixed assets21/28€103k€85k▼
Tangible fixed assets22/27€103k€85k▼
Land and buildings22-€1k
Plant, machinery and equipment23€2k€2k▼
Furniture and vehicles24€101k€81k▼
Current assets29/58€716k€306k▼
Amounts receivable within one year40/41€287k€246k▼
Trade receivables40€207k€246k▲
Other amounts receivable41€79k-
Current investments50/53€350k-
Cash at bank and in hand54/58€65k€54k▼
Deferred charges and accrued income490/1€14k€6k▼
Equity and liabilities
Total equity and liabilities10/49€819k€391k▼
Equity10/15€646k€248k▼
Contributions10/11€1k€1k=
Reserves13€645k€247k▼
Distributable reserves133€645k€247k▼
Amounts payable17/49€173k€143k▼
Amounts payable after more than one year17€80k€61k▼
Financial debts170/4€80k€61k▼
Amounts payable within one year42/48€92k€78k▼
Current portion of amounts payable after more than one year42€19k€19k▲
Trade debts44€3k€3k▼
Suppliers440/4€3k€3k▼
Taxes, remuneration and social security45€71k€4k▼
Taxes450/3€67k€4k▼
Remuneration and social security454/9€4k-
Other amounts payable47/48-€51k
Accrued charges and deferred income492/3€1k€5k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€23k▲
Other operating charges640/8€115€126▲
Gross operating margin9900€270k€348k▲
Operating profit (loss)9901€264k€325k▲
Financial income75/76B€3k€9k▲
Recurring financial income75€3k€9k▲
Financial charges65/66B€1k€8k▲
Recurring financial charges65€1k€8k▲
Profit (loss) for the period before taxes9903€266k€326k▲
Income taxes67/77€65k€79k▲
Profit (loss) for the period9904€201k€247k▲
Profit (loss) for the period to be appropriated9905€201k€247k▲
Appropriation of the result
Profit (loss) to be appropriated9906€201k€247k▲
Transfer from equity791/2-€645k
Transfer to equity691/2€201k€247k▲
To other reserves6921€201k€247k▲
Profit to be distributed694/7-€645k
Return on contributions (dividend)694-€645k
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
15-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
Financial
Highest result since 2022net €247k ▲22.8%
Operating result €325k, net result €247k, both a record.
16-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-06
Financial
Weakest financial yearnet €201k ▼6.8%
Net result drops to €201k, the lowest in the series; recovery starts the following year.
30-06
Financial
Equity above €500kEq €646k ▲45.2%
3 profitable years in a row build equity to €646k.
29-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
24-01
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Roeselare · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Vlietputweg 28800 RoeselareGround area
17.4 ha
Building footprint
2.4 ha
Volume, LiDAR
1,214 m³
2 parcels, Flanders · tallest building 6.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Heleen Maes
since 20212.326.070.292
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 36017A1048/00B000 | Flanders | 16.7 ha | 1 · 2.4 ha | - |
| 36017C1513/00H000 | Flanders | 6,244 m² | 1 · 234 m² | 6.8 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
LA COURONNE- Cabinet médical
BE 0473.828.865
Les Bons Villers · Eq €247,767
CSML GO
BE 0795.349.421
Denderleeuw · Eq €247,609
Dr. VAN AKEN DAVID
BE 0820.005.633
Schoten · Eq €247,478
DR. VERBEERST LORENTZ
BE 0694.956.104
Nazareth-De Pinte · Eq €247,391
Dr. Loran Defruyt, Cardioloog
BE 0754.724.831
Dentergem · Eq €248,152
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,661 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded09-11-2021
Fiscal year end30-06
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.